Results 331 to 340 of about 1,321,964 (375)

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

New England Journal of Medicine, 1989
We measured antibody (anti-HCV) to hepatitis C virus, which causes non-A, non-B hepatitis, by radioimmunoassay in prospectively followed transfusion recipients and their donors.
H. Alter, R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. Choo, G. Kuo   +6 more
semanticscholar   +1 more source

Hepatitis C virus genotypes in chronic hepatitis C of children

Journal of Viral Hepatitis, 1996
SUMMARY.Several hepatitis C virus (HCV) genotypes have been recently identified and genotype 1b has been correlated with severe liver disease and a poor response to interferon therapy. HCV infection in children is an interesting model for evaluation of the relationship between HCV genotypes and liver disease, because of its relatively short duration ...
BORTOLOTTI, FLAVIA, VAJRO P, BALLI F, GIACCHINO R, CRIVELLARO C, BARBERA C, PONTISSO, PATRIZIA, NEBBIA C, ZANCAN, LUCIA, BERTOLINI A, ALBERTI, ALFREDO   +10 more
openaire   +6 more sources

Curing chronic hepatitis C--the arc of a medical triumph.

New England Journal of Medicine, 2014
The development of direct-acting antiviral agents has revolutionized the treatment of hepatitis C by offering genuine prospects for a comprehensive cure of a chronic viral infection.
R. Chung, T. Baumert
semanticscholar   +1 more source

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Gastroenterology, 2010
BACKGROUND & AIMS Hepatitis C virus (HCV) induces chronic infection in 50% to 80% of infected persons; approximately 50% of these do not respond to therapy.
A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. di Iulio, T. Mueller, M. Bochud, M. Battegay, E. Bernasconi, J. Borovička, S. Colombo, A. Cerny, J. Dufour, H. Furrer, H. Günthard, M. Heim, B. Hirschel, R. Malinverni, D. Moradpour, B. Müllhaupt, A. Witteck, J. Beckmann, T. Berg, S. Bergmann, F. Negro, A. Telenti, P. Bochud   +26 more
semanticscholar   +1 more source

Bicyclol for chronic hepatitis C

Cochrane Database of Systematic Reviews, 2006
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis B. Until now, systematic reviews of bicyclol therapy have not been performed.To study the benefits and harms of bicyclol for patients with chronic hepatitis B.We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (July 2005), The Cochrane Central
T, Wu, H, Roger, L, Xie, G, Liu, B, Hao
openaire   +4 more sources

Antifibrotics for Chronic Hepatitis C

Clinics in Liver Disease, 2009
Development and testing of antifibrotic agents for the treatment of chronic hepatitis C have generally been targeted toward hepatic stellate cells, transforming growth factor-beta, the inflammatory response, or extracellular matrix accumulation. Although several agents such as interferon-gamma, long-term pegylated interferon, and caspase inhibitors ...
openaire   +3 more sources

Economics of chronic hepatitis B and hepatitis C

Journal of Hepatology, 2007
Although not all patients develop progressive liver disease, chronic hepatitis B and chronic hepatitis C infections cause substantial morbidity and mortality worldwide. To address this need, many new antiviral treatments have become available over the past 10 years.
Arathi Rajendra, John B. Wong
openaire   +2 more sources

Hepatic sarcoidosis associated with chronic hepatitis C

Journal of Gastroenterology, 2002
A 57-year-old woman with sarcoidosis was referred because of the appearance of multiple small low-attenuation areas in the liver on computed tomography (CT). A liver biopsy specimen showed chronic active hepatitis accompanied by sarcoid granulomas. The patient received prednisolone and, later, interferon-alpha.
Sumiya Eto, Takeshi Fujisaki, Shinichiro Mine, Yoshiya Tanaka, Norihiro Ohnari, Shinwa Yamada   +5 more
openaire   +3 more sources

Natural history of liver fibrosis progression in patients with chronic hepatitis C

The Lancet, 1997
T. Poynard, P. Bedossa, P. Opolon, Metavir Clinivir and Dosvirc groups for the OBSVIRC   +3 more
semanticscholar   +1 more source

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

Nature Genetics, 2009
V. Suppiah, Max Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, M. Abate, M. Bassendine, U. Spengler, G. Dore, E. Powell, S. Riordan, D. Sheridan, A. Smedile, V. Fragomeli, T. Müller, M. Bahlo, G. Stewart, D. Booth, J. George   +18 more
semanticscholar   +1 more source